In 2025, Stanford University PhD student Samuel King employed a generative AI model to develop genetic blueprints for microscopic viruses, according to MIT Technology Review. This innovative approach represents a significant advancement in AI-driven biological research.
MIT Technology Review also recognized King as one of its Innovators Under 35, highlighting his notable contributions to the intersection of artificial intelligence and genetics. His work reflects growing trends in using AI to accelerate scientific discovery.
For Japanese markets, this development underscores the increasing role of AI technologies in biotech sectors, which could influence investment strategies in both domestic and international equities and emerging technologies.